How much more effective do depot antipsychotics have to be compared to oral antipsychotics before they are prescribed?

European Neuropsychopharmacology

Volumn 20, Issue 4, 2010, Pages 276-279

  Hamann, Johannes ^a   Mendel, Rosmarie ^a   Heres, Stephan ^a   Leucht, Stefan ^a   Kissling, Werner ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Antipsychotics; Depot; Effectiveness; Prescription rates; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; AGE; ARTICLE; CONTROLLED RELEASE FORMULATION; DEPOT FORMULATION; EXPERIMENTAL STUDY; FEMALE; GENDER; HUMAN; JOB EXPERIENCE; MALE; PATIENT COMPLIANCE; PHYSICIAN ATTITUDE; PRESCRIPTION; PRIORITY JOURNAL; PSYCHIATRIST; RELAPSE; RISK; SCHIZOPHRENIA; WORKPLACE;

ADMINISTRATION, ORAL; ANTIPSYCHOTIC AGENTS; ATTITUDE OF HEALTH PERSONNEL; CHOICE BEHAVIOR; DELAYED-ACTION PREPARATIONS; FEMALE; HEALTH CARE SURVEYS; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PSYCHIATRY;

EID: 77349085078     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2010.01.001     Document Type: Article

References (16)

1. Adams C.E., Fenton M.K., Quraishi S., and David A.S. Systematic meta-review of depot antipsychotic drugs for people with schizophrenia. Br. J. Psychiatry 179 (2001) 290-299
2. Bloch Y., Mendlovic S., Strupinsky S., Altshuler A., Fennig S., and Ratzoni G. Injections of depot antipsychotic medications in patients suffering from schizophrenia: do they hurt?. J. Clin. Psychiatry 62 (2001) 855-859
3. Byerly M., Fischer R., and Rush A. A comparison of clinician vs. electronic monitoring of antipsychotic adherence in schizophrenia. Presented at the 41st annual meeting of the American College of Neuropsychopharmacology. San Juan, Puerto Rico (2002)
4. Cholesterol Treatment Trialists' (CTT) Collaborators, Kearney P.M., Blackwell L., Collins R., Keech A., Simes J., Peto R., Armitage J., and Baigent C. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet 371 (2008) 117-125
5. Dibonaventura M., and Chapman G.B. Do decision biases predict bad decisions? Omission bias, naturalness bias, and influenza vaccination. Med. Decis. Making 28 (2008) 532-539
6. Fleischhacker W.W. Second-generation antipsychotic long-acting injections: systematic review. Br. J. Psychiatry 195 (2009) s29-s36
7. Haddad P.M., Taylor M., and Niaz O.S. First-generation antipsychotic long-acting injections v. oral antipsychotics in schizophrenia: systematic review of randomized controlled trials and observational studies. Br. J. Psychiatry 195 (2009) s20-s28
8. Hamann J., Pfeiffer H., Leucht S., and Kissling W. Are patients with schizophrenia under-treated with second-generation antipsychotics? A pilot study of the prescription practices of German psychiatrists. Pharmacopsychiatry 36 6 (2003) 309-312
9. Hamann J., Leucht S., and Kissling W. Shared decision making in psychiatry. Acta Psychiatr. Scand. 107 (2003) 403-409
10. Heres S., Hamann J., Kissling W., and Leucht S. Attitudes of psychiatrists toward antipsychotic depot medication. J. Clin. Psychiatry 67 (2006) 1948-1953
11. Heres S., Schmitz F.S., Leucht S., and Pajonk F.G. The attitude of patients towards antipsychotic depot treatment. Int. Clin. Psychopharmacol. 22 (2007) 275-282
12. Jaeger M., and Rössler W. Attitudes towards long-acting depot antipsychotics: a survey of patients, relatives and psychiatrists. Psychiatry Res 1-2 (2010) 58-62
13. Patel M.X., Nikolaou V., and David A.S. Psychiatrists' attitudes to maintenance medication for patients with schizophrenia. Psychol. Med. 33 (2003) 83-89
14. Patel M.X., Taylor M., and David A.S. Antipsychotic long-acting injections: mind the gap. Br. J. Psychiatry 195 (2009) s1-s4
15. Patel MX, Haddad PM, Chaudhry IB, McLoughlin S, Husain N, David AS, in press. Psychiatrists' use, knowledge and attitudes to first- and second-generation antipsychotic long-acting injections: comparisons over 5 years. J. Psychopharmacol.doi:10.1177/0269881109104882.
16. Sim K., Su A., Ungvari G.S., Fujii S., Yang S.Y., Chong M.Y., Si T., Chung E.K., Tsang H.Y., Chan Y.H., Shinfuku N., and Tan C.H. Depot antipsychotic use in schizophrenia: an East Asian perspective. Hum. Psychopharmacol. 19 2 (2004) 103-109